Carbidopa API manufacturer

Product Code: 4037809 Product Code GMP: 1610-GMP

Hero_subpage_img
Pattern
Pattern

Key Information

Regulatory Documentation

DMF: available

CEP: available

Chemical Identifiers

CAS Number(s):

  • 28860-95-9 (net)
  • 38821-49-7 (monohydrate)

Synonyms:

  • α-Methyldopahydrazine
  • (S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid · H2O
  • (S)-α-Hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid monohydrate
  • (-)-L-α-Hydrazino-3,4-dihydroxy-α-methylhydrocinnamic acid monohydrate

Sequence

n.a.

Fields of Application

Parkinson’s Disease

Active Substance

Carbidopa is a peripheral dopa-decarboxylase inhibitor which exhibits a distinct pharmacological activity only when given in combination with levodopa. Carbidopa inhibits the peripheral decarboxylation of levodopa to dopamine. As, unlike levodopa, carbidopa does not cross the blood-brain barrier, effective brain concentrations of dopamine are produced with lower doses of levodopa.

In the treatment of parkinsonism carbidopa is administered in combination with levodopa to allow a lower dosage of the latter, a more rapid onset of a response, and a mitigation of adverse effects.

Molecular Information

Molecular Formula:

C10H14N2O4 · H2O

Relative Molecular Mass:

226.23 g/mol (net) 244.25 g/mol (monohydrate)

Long-term Storage:

Room temperature

Why choose Bachem for your Carbidopa Supply

Proven API Expertise

Decades of experience in peptide and small‑molecule synthesis enable Bachem to deliver consistently high‑quality carbidopa.

GMP-certified Precision

Strict GMP compliance and rigorous quality control ensure every batch of carbidopa meets the highest regulatory and purity standards.

Secure, Reliable Supply

In‑house production of starting materials and robust inventory management safeguard your supply chain from disruptions.

Scalable Manufacturing Capacity

State‑of‑the‑art facilities support flexible order sizes—from grams to hundreds of kilograms—without compromising timelines.

Comprehensive Regulatory Support

Access to DMFs, CEPs, and expert regulatory guidance streamlines your approval processes and accelerates market readiness.

Customer-centric Partnership

Bachem’s responsive service, technical expertise, and tailored solutions create a dependable, long‑term API manufacturing partnership.

Shaping the Future

Driving Generic Drugs Together

Rely on our years of experience in manufacturing APIs for your next commercial drug venture.

Additional Information on Carbidopa

What is carbidopa?

Carbidopa is a medication often used alongside levodopa to help manage Parkinson’s disease. By working together, they improve the treatment of symptoms like tremors, stiffness, and slow movement. Carbidopa is particularly important because it enhances levodopa’s effectiveness while also reducing side effects such as nausea. This makes it easier for patients to tolerate their treatment and experience better overall results.

Carbidopa mechanism of action

Carbidopa primarily acts by inhibiting the enzyme aromatic L-amino acid decarboxylase, which is responsible for converting levodopa into dopamine outside the brain. By preventing this conversion in the peripheral tissues, carbidopa ensures that more levodopa reaches the brain intact, where it can be transformed into dopamine. This not only maximizes the therapeutic effect of levodopa but also reduces side effects associated with excess dopamine production in the body, such as nausea and vomiting. As a result, carbidopa enhances the overall efficacy of Parkinson’s disease treatment, helping to improve patients’ quality of life.

What is carbidopa used for?

Carbidopa is widely used to help manage symptoms of Parkinson’s disease when combined with levodopa. This combination is effective in reducing symptoms like tremors, stiffness, and slow movement, which can significantly impact daily life. By allowing more levodopa to reach the brain, carbidopa enhances its benefits while reducing common side effects, such as nausea, that often arise when levodopa is taken on its own.

In some cases, carbidopa is also used for other movement disorders with similar dopamine-related symptoms, making it a versatile choice for long-term symptom management.

Related Generic APIs